# ARFGEF2

## Overview
The ARFGEF2 gene encodes the protein ADP ribosylation factor guanine nucleotide exchange factor 2, commonly referred to as BIG2. BIG2 is a guanine nucleotide exchange factor (GEF) that plays a pivotal role in cellular processes by regulating the activity of ADP-ribosylation factors (ARFs), which are small GTP-binding proteins involved in vesicle trafficking. This protein is essential for the proper functioning of vesicle and membrane trafficking from the trans-Golgi network to endosomes and the cell surface, processes that are critical for various cellular functions, including neural progenitor proliferation and migration in the cerebral cortex. BIG2's interactions with other proteins, such as Rho GTPases and ARF1, underscore its role as a scaffold in signaling pathways that influence dendrite development and Golgi apparatus polarization. Mutations in the ARFGEF2 gene are linked to neurological and developmental disorders, highlighting its clinical significance in brain development and function (Sheen2003Mutations; Yilmaz2016The; Hong2018BIG2ARF1RhoAmDia1).

## Function
The ARFGEF2 gene encodes the protein BIG2, which functions as a guanine nucleotide exchange factor (GEF) for ADP-ribosylation factors (ARFs), small GTP-binding proteins involved in vesicle trafficking. BIG2 is crucial for the regulation of vesicle and membrane trafficking from the trans-Golgi network (TGN) to endosomes and the cell surface, a process essential for cellular functions such as neural progenitor proliferation and migration in the human cerebral cortex (Sheen2003Mutations).

BIG2 facilitates the cycling of ARFs between inactive GDP-bound and active GTP-bound forms, which is necessary for the assembly of coat proteins around intracellular vesicles in a GTP-dependent manner. This regulation is vital for vesicle cycling and the proper localization of proteins like E-cadherin and β-catenin, which are important for cell adhesion and signaling pathways (Sheen2003Mutations; Lu2005Overlapping).

In the context of neural development, ARFGEF2 is expressed in neural progenitors along the neuroependymal lining of the ventricular zone, playing a role in the targeted transport of proteins such as Filamin A (FLNA) to the cell surface. Disruptions in this process can lead to developmental disorders like periventricular heterotopia (Lu2005Overlapping).

## Clinical Significance
Mutations in the ARFGEF2 gene are associated with several neurological and developmental disorders, primarily characterized by periventricular nodular heterotopia (PNH) and microcephaly. These conditions result from abnormal neuronal migration during brain development, leading to nodules on the ventricular surface (Sheen2003Mutations; Yilmaz2016The). The gene mutations are inherited in an autosomal recessive manner and have been identified in various populations, including Turkish and Dutch families (Sheen2003Mutations; Tanyalçin2013Elaborating).

Clinical manifestations of ARFGEF2 mutations include severe developmental delay, microcephaly, movement disorders, and epilepsy. MRI findings often reveal periventricular heterotopias, putaminal hyperintensity, and cortical atrophy (Yilmaz2016The; de2009Movement). In some cases, cardiomyopathy has also been reported, suggesting it may be part of the phenotypic spectrum associated with ARFGEF2 mutations (Yilmaz2016The).

The ARFGEF2 gene encodes the BIG2 protein, which is crucial for vesicle trafficking and membrane dynamics. Disruptions in these processes due to ARFGEF2 mutations can impair neural progenitor proliferation and migration, contributing to the observed neurological abnormalities (Sheen2003Mutations; Grzmil2010Early).

## Interactions
ARFGEF2, also known as BIG2, is involved in several protein interactions that are crucial for its role in cellular processes. BIG2 interacts with Rho GTPases, specifically binding to constitutively active forms of RhoA, Cdc42, and Rac1, suggesting it may function as a scaffold for active Rho GTPases (Hong2018BIG2ARF1RhoAmDia1). It also interacts with ARF1, a Class I ARF, which is necessary for dendrite development and Golgi apparatus polarization in neurons (Hong2018BIG2ARF1RhoAmDia1). The interaction between BIG2 and ARF1 is essential for activating the RhoA-mDia1 signaling pathway, which promotes Golgi-tubule formation and positioning into dendrites (Hong2018BIG2ARF1RhoAmDia1).

BIG2 is also identified as an A-kinase anchoring protein (AKAP) that interacts with the regulatory subunit RII of protein kinase A (PKA) and can be phosphorylated by PKA, which decreases its GEF activity (Bui2009Large). Additionally, protein phosphatase 1 (PP1) is found in a complex with BIG2, indicating a physical association (Bui2009Large). These interactions highlight the role of ARFGEF2 in coordinating signaling pathways and membrane trafficking processes.


## References


[1. (de2009Movement) M. C. Y. de Wit, I. F. M. de Coo, D. J. J. Halley, M. H. Lequin, and G. M. S. Mancini. Movement disorder and neuronal migration disorder due to arfgef2 mutation. neurogenetics, 10(4):333–336, April 2009. URL: http://dx.doi.org/10.1007/s10048-009-0192-2, doi:10.1007/s10048-009-0192-2. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-009-0192-2)

[2. (Bui2009Large) Quynh Trang Bui, Marie-Pierre Golinelli-Cohen, and Catherine L. Jackson. Large arf1 guanine nucleotide exchange factors: evolution, domain structure, and roles in membrane trafficking and human disease. Molecular Genetics and Genomics, 282(4):329–350, August 2009. URL: http://dx.doi.org/10.1007/s00438-009-0473-3, doi:10.1007/s00438-009-0473-3. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00438-009-0473-3)

[3. (Grzmil2010Early) Pawel Grzmil, Zanabazar Enkhbaatar, Batjargal Gundsambuu, Odgerel Oidovsambuu, Safak Yalcin, Stephan Wolf, Wolfgang Engel, and Jrgen Neesen. Early embryonic lethality in gene trap mice with disruption of the arfgef2 gene. The International Journal of Developmental Biology, 54(8–9):1259–1266, 2010. URL: http://dx.doi.org/10.1387/ijdb.092959pg, doi:10.1387/ijdb.092959pg. This article has 16 citations.](https://doi.org/10.1387/ijdb.092959pg)

[4. (Yilmaz2016The) Sanem Yilmaz, Sarenur Gokben, Gul Serdaroglu, Cenk Eraslan, Grazia M.S. Mancini, Hande Tekin, and Hasan Tekgul. The expanding phenotypic spectrum of arfgef2 gene mutation: cardiomyopathy and movement disorder. Brain and Development, 38(1):124–127, January 2016. URL: http://dx.doi.org/10.1016/j.braindev.2015.06.004, doi:10.1016/j.braindev.2015.06.004. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.braindev.2015.06.004)

[5. (Tanyalçin2013Elaborating) Ibrahim Tanyalçin, Helene Verhelst, Dicky J.J. Halley, Tim Vanderhasselt, Laurent Villard, Cyril Goizet, Willy Lissens, Grazia M. Mancini, and Anna C. Jansen. Elaborating the phenotypic spectrum associated with mutations in arfgef2: case study and literature review. European Journal of Paediatric Neurology, 17(6):666–670, November 2013. URL: http://dx.doi.org/10.1016/j.ejpn.2013.05.002, doi:10.1016/j.ejpn.2013.05.002. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejpn.2013.05.002)

[6. (Sheen2003Mutations) Volney L Sheen, Vijay S Ganesh, Meral Topcu, Guillaume Sebire, Adria Bodell, R Sean Hill, P Ellen Grant, Yin Yao Shugart, Jaime Imitola, Samia J Khoury, Renzo Guerrini, and Christopher A Walsh. Mutations in arfgef2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nature Genetics, 36(1):69–76, November 2003. URL: http://dx.doi.org/10.1038/ng1276, doi:10.1038/ng1276. This article has 305 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng1276)

[7. (Hong2018BIG2ARF1RhoAmDia1) Eun-Hye Hong, Ji-Ye Kim, Jeong-Hoon Kim, Dae-Sik Lim, Minkyu Kim, and Jeong-Yoon Kim. Big2-arf1-rhoa-mdia1 signaling regulates dendritic golgi polarization in hippocampal neurons. Molecular Neurobiology, 55(10):7701–7716, February 2018. URL: http://dx.doi.org/10.1007/s12035-018-0954-7, doi:10.1007/s12035-018-0954-7. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-018-0954-7)

[8. (Lu2005Overlapping) Jie Lu, Grace Tiao, Rebecca Folkerth, Jonathon Hecht, Christopher Walsh, and Volney Sheen. Overlapping expression of arfgef2 and filamin a in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia. The Journal of Comparative Neurology, 494(3):476–484, 2005. URL: http://dx.doi.org/10.1002/cne.20806, doi:10.1002/cne.20806. This article has 41 citations.](https://doi.org/10.1002/cne.20806)